P

Inventor

TILLEY JEFFERSON W

US31 patents
⚠️ This page may combine multiple inventors who share the name “TILLEY JEFFERSON W”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

HOFFMANN LA ROCHE

28 patents
US4916145AApr 10, 1990

Substituted n-[(pyridyl)alkyl]aryl-carboxamide

HOFFMANN LA ROCHE74 citations96
US4927838AMay 22, 1990

Pyridine compounds which are useful in treating a disease state characterized by an excess of platelet activating factors

HOFFMANN LA ROCHE101 citations93
US5182263AJan 26, 1993

Analogs of tyrosine sulfate or tyrosine phosphate containing peptides

HOFFMANN LA ROCHE23 citations92
US5128448AJul 7, 1992

CCK analogs with appetite regulating activity

HOFFMANN LA ROCHE30 citations92
US4788206ANov 29, 1988

Pentadieneamides

HOFFMANN LA ROCHE32 citations92
US4786646ANov 22, 1988

Cyclopropylpropenamides

HOFFMANN LA ROCHE42 citations92
US4169154ASep 25, 1979

Method of treating depression with thiourea derivatives

HOFFMANN LA ROCHE43 citations91
US5344843ASep 6, 1994

Cat-1 inhibitors, pharmaceutical compositions and methods of use

HOFFMANN LA ROCHE28 citations88
US4304721ADec 8, 1981

Adrenergic blocking agents

HOFFMANN LA ROCHE25 citations81
US4551460ANov 5, 1985

Pyrido[2,1-b]quinazoline derivatives useful as agents for treatment of allergic conditions and vascular disorders involving thrombosis

HOFFMANN LA ROCHE10 citations74
US4348396ASep 7, 1982

Substituted 11-oxo-11H-pyrido[2,1-b]quinazolines and method of inhibiting allergic reactions with them

HOFFMANN LA ROCHE8 citations74
US4281189AJul 28, 1981

Sulfonamide intermediates for adrenergic blocking agents

HOFFMANN LA ROCHE9 citations74
US5508437AApr 16, 1996

Analogs of tyrosine sulfate or tyrosine phosphate containing peptides

HOFFMANN LA ROCHE14 citations73
US5296608AMar 22, 1994

Intermediates for analogs of tyrosine sulfate or tyrosine phosphate containing peptides

HOFFMANN LA ROCHE14 citations73
US4927826AMay 22, 1990

Cycloproylpropenamides useful as platelet activing factor (PAF) antagonists

HOFFMANN LA ROCHE10 citations73
US4329289AMay 11, 1982

Adrenergic blocking agents

HOFFMANN LA ROCHE10 citations73
US4285873AAug 25, 1981

Adrenergic blocking agents

HOFFMANN LA ROCHE9 citations73
US4247710AJan 27, 1981

Intermediate in the production of adrenergic blocking agents

HOFFMANN LA ROCHE12 citations73
US4202978AMay 13, 1980

(S)-1-[2-(4-(2-Hydroxy-s-(1-alkylaminopropoxy)phenylalkyl]-4-phenylpiperazines

HOFFMANN LA ROCHE18 citations73
US4599336AJul 8, 1986

Derivatives of (E)-3-(4-oxo-4H-quinazolin-3-yl)-2-propenamide

HOFFMANN LA ROCHE7 citations69
US4975438ADec 4, 1990

Pentadieneamide compounds which have useful activity of treating a disease characterized by an excess of platelet activating factor

HOFFMANN LA ROCHE3 citations62
US4336382AJun 22, 1982

1,4-Disubstituted piperazine compounds

HOFFMANN LA ROCHE4 citations62
US4150138AApr 17, 1979

Method of reducing blood pressure with thiourea derivatives and guanidine derivatives

HOFFMANN LA ROCHE4 citations61
US4891429AJan 2, 1990

Antiarrhythmic agents

HOFFMANN LA ROCHE0 citations51
US4696930ASep 29, 1987

N-(heteroarylalkyl)acylanilide derivatives as antiarrhythmic agents

HOFFMANN LA ROCHE0 citations51
US4314085AFeb 2, 1982

Intermediates for preparing adrenergic blocking agents

HOFFMANN LA ROCHE1 citations51
US4301300ANov 17, 1981

Sulfonamide intermediates for adrenergic blocking agents

HOFFMANN LA ROCHE0 citations51
US4288454ASep 8, 1981

Antiviral 1-adamantyl-3-(phenylsulfonyl)thioureas

HOFFMANN LA ROCHE1 citations51

GAWECO ANDERSON

2 patents

INNOV17 LLC

1 patent